AI Applications in Healthcare Discussion Transcript

This document is a transcript of a discussion at the VIVE Conference featuring Claudia Douglass from Grant Thornton and Dr. Peter Pronovost from University Hospitals. The conversation primarily focuses on the use of artificial intelligence (AI) in healthcare, particularly in clinical and non-clinical settings. Douglass introduces the topic and engages the audience to understand their experience with AI in healthcare. Pronovost discusses the regulatory challenges posed by the FDA, which limit the use of AI in clinical applications compared to non-clinical areas. He highlights the cost issues faced by health systems and the need for effective management systems to address waste and improve care delivery. The dialogue also touches on the importance of reducing unnecessary policies to streamline operations and enhance productivity. Additionally, Pronovost emphasizes the distinction between augmented intelligence and artificial intelligence, advocating for a more integrated approach to using AI in healthcare. The discussion concludes with insights into the future of AI in the industry.